Mannatech (NASDAQ:MTEX) Earns Buy Rating from Analysts at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX) in a research report issued on Friday. The firm set a “buy” rating on the stock.

Mannatech Stock Down 3.7 %

Mannatech stock opened at $11.44 on Friday. The firm has a 50 day moving average price of $8.82 and a 200-day moving average price of $7.88. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44. Mannatech has a twelve month low of $6.75 and a twelve month high of $13.00. The company has a market capitalization of $21.56 million, a P/E ratio of -14.12 and a beta of 1.18.

Mannatech (NASDAQ:MTEX) last announced its quarterly earnings data on Tuesday, November 12th. The company reported ($0.17) earnings per share for the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%. The firm had revenue of $31.73 million for the quarter.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.